 | • レポートコード：GIR-23F3762 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Brand Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界のブランド医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ブランド医薬品市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・バイオ医薬品、ケミカル医薬品 アプリケーション別セグメントは次のように区分されます。 ・病院、診療所、その他 世界のブランド医薬品市場の主要なマーケットプレーヤーは以下のとおりです。 ・Pfizer、Roche、Sanofi、Johnson & Johnson、Merck & Co. (MSD)、Novartis、AbbVie、Gilead Sciences、GlaxoSmithKline (GSK)、Amgen、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Teva、Bayer、Novo Nordisk、Allergan、Takeda、Boehringer Ingelheim、Takeda 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - ブランド医薬品の概要 - タイプ別分析（2017年vs2021年vs2028年）：バイオ医薬品、ケミカル医薬品 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、診療所、その他 - 世界のブランド医薬品市場規模・予測 - 世界のブランド医薬品生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pfizer、Roche、Sanofi、Johnson & Johnson、Merck & Co. (MSD)、Novartis、AbbVie、Gilead Sciences、GlaxoSmithKline (GSK)、Amgen、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Teva、Bayer、Novo Nordisk、Allergan、Takeda、Boehringer Ingelheim、Takeda ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：バイオ医薬品、ケミカル医薬品 ・アプリケーション別分析2017年-2028年：病院、診療所、その他 ・ブランド医薬品の北米市場分析 - ブランド医薬品の北米市場：タイプ別市場規模2017年-2028年 - ブランド医薬品の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ブランド医薬品のヨーロッパ市場分析 - ：ブランド医薬品のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：ブランド医薬品のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ブランド医薬品のアジア太平洋市場分析 - ブランド医薬品のアジア太平洋市場：タイプ別市場規模2017年-2028年 - ブランド医薬品のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ブランド医薬品の南米市場分析 - ブランド医薬品の南米市場：タイプ別市場規模2017年-2028年 - ブランド医薬品の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ブランド医薬品の中東・アフリカ市場分析 - ブランド医薬品の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - ブランド医薬品の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Brand Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Brand Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Brand Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biopharmaceutical segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Brand Drugs include Pfizer, Roche, Sanofi, Johnson & Johnson, and Merck & Co. (MSD), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Brand Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Biopharmaceutical
Chemistry Medicine
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Brand Drugs market are listed below:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Takeda
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Brand Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Brand Drugs, with price, sales, revenue and global market share of Brand Drugs from 2019 to 2022.
Chapter 3, the Brand Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Brand Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Brand Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Brand Drugs.
Chapter 13, 14, and 15, to describe Brand Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Brand Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Brand Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Biopharmaceutical
1.2.3 Chemistry Medicine
1.3 Market Analysis by Application
1.3.1 Overview: Global Brand Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Brand Drugs Market Size & Forecast
1.4.1 Global Brand Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Brand Drugs Sales in Volume (2017-2028)
1.4.3 Global Brand Drugs Price (2017-2028)
1.5 Global Brand Drugs Production Capacity Analysis
1.5.1 Global Brand Drugs Total Production Capacity (2017-2028)
1.5.2 Global Brand Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Brand Drugs Market Drivers
1.6.2 Brand Drugs Market Restraints
1.6.3 Brand Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Brand Drugs Product and Services
2.1.4 Pfizer Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Brand Drugs Product and Services
2.2.4 Roche Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Brand Drugs Product and Services
2.3.4 Sanofi Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Brand Drugs Product and Services
2.4.4 Johnson & Johnson Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck & Co. (MSD)
2.5.1 Merck & Co. (MSD) Details
2.5.2 Merck & Co. (MSD) Major Business
2.5.3 Merck & Co. (MSD) Brand Drugs Product and Services
2.5.4 Merck & Co. (MSD) Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Brand Drugs Product and Services
2.6.4 Novartis Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business
2.7.3 AbbVie Brand Drugs Product and Services
2.7.4 AbbVie Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Gilead Sciences
2.8.1 Gilead Sciences Details
2.8.2 Gilead Sciences Major Business
2.8.3 Gilead Sciences Brand Drugs Product and Services
2.8.4 Gilead Sciences Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 GlaxoSmithKline (GSK)
2.9.1 GlaxoSmithKline (GSK) Details
2.9.2 GlaxoSmithKline (GSK) Major Business
2.9.3 GlaxoSmithKline (GSK) Brand Drugs Product and Services
2.9.4 GlaxoSmithKline (GSK) Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Brand Drugs Product and Services
2.10.4 Amgen Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Brand Drugs Product and Services
2.11.4 AstraZeneca Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Bristol-Myers Squibb
2.12.1 Bristol-Myers Squibb Details
2.12.2 Bristol-Myers Squibb Major Business
2.12.3 Bristol-Myers Squibb Brand Drugs Product and Services
2.12.4 Bristol-Myers Squibb Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Brand Drugs Product and Services
2.13.4 Eli Lilly Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Teva
2.14.1 Teva Details
2.14.2 Teva Major Business
2.14.3 Teva Brand Drugs Product and Services
2.14.4 Teva Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Brand Drugs Product and Services
2.15.4 Bayer Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Novo Nordisk
2.16.1 Novo Nordisk Details
2.16.2 Novo Nordisk Major Business
2.16.3 Novo Nordisk Brand Drugs Product and Services
2.16.4 Novo Nordisk Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Allergan
2.17.1 Allergan Details
2.17.2 Allergan Major Business
2.17.3 Allergan Brand Drugs Product and Services
2.17.4 Allergan Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Takeda
2.18.1 Takeda Details
2.18.2 Takeda Major Business
2.18.3 Takeda Brand Drugs Product and Services
2.18.4 Takeda Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Boehringer Ingelheim
2.19.1 Boehringer Ingelheim Details
2.19.2 Boehringer Ingelheim Major Business
2.19.3 Boehringer Ingelheim Brand Drugs Product and Services
2.19.4 Boehringer Ingelheim Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Takeda
2.20.1 Takeda Details
2.20.2 Takeda Major Business
2.20.3 Takeda Brand Drugs Product and Services
2.20.4 Takeda Brand Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Brand Drugs Breakdown Data by Manufacturer
3.1 Global Brand Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Brand Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Brand Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Brand Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Brand Drugs Manufacturer Market Share in 2021
3.5 Global Brand Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Brand Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Brand Drugs Market Size by Region
4.1.1 Global Brand Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Brand Drugs Revenue by Region (2017-2028)
4.2 North America Brand Drugs Revenue (2017-2028)
4.3 Europe Brand Drugs Revenue (2017-2028)
4.4 Asia-Pacific Brand Drugs Revenue (2017-2028)
4.5 South America Brand Drugs Revenue (2017-2028)
4.6 Middle East and Africa Brand Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Brand Drugs Sales in Volume by Type (2017-2028)
5.2 Global Brand Drugs Revenue by Type (2017-2028)
5.3 Global Brand Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Brand Drugs Sales in Volume by Application (2017-2028)
6.2 Global Brand Drugs Revenue by Application (2017-2028)
6.3 Global Brand Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Brand Drugs Sales by Type (2017-2028)
7.2 North America Brand Drugs Sales by Application (2017-2028)
7.3 North America Brand Drugs Market Size by Country
7.3.1 North America Brand Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Brand Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Brand Drugs Sales by Type (2017-2028)
8.2 Europe Brand Drugs Sales by Application (2017-2028)
8.3 Europe Brand Drugs Market Size by Country
8.3.1 Europe Brand Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Brand Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Brand Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Brand Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Brand Drugs Market Size by Region
9.3.1 Asia-Pacific Brand Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Brand Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Brand Drugs Sales by Type (2017-2028)
10.2 South America Brand Drugs Sales by Application (2017-2028)
10.3 South America Brand Drugs Market Size by Country
10.3.1 South America Brand Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Brand Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Brand Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Brand Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Brand Drugs Market Size by Country
11.3.1 Middle East & Africa Brand Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Brand Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Brand Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Brand Drugs
12.3 Brand Drugs Production Process
12.4 Brand Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Brand Drugs Typical Distributors
13.3 Brand Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Brand Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Brand Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Brand Drugs Product and Services
Table 6. Pfizer Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Major Business
Table 9. Roche Brand Drugs Product and Services
Table 10. Roche Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Brand Drugs Product and Services
Table 14. Sanofi Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Brand Drugs Product and Services
Table 18. Johnson & Johnson Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck & Co. (MSD) Basic Information, Manufacturing Base and Competitors
Table 20. Merck & Co. (MSD) Major Business
Table 21. Merck & Co. (MSD) Brand Drugs Product and Services
Table 22. Merck & Co. (MSD) Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Brand Drugs Product and Services
Table 26. Novartis Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. AbbVie Basic Information, Manufacturing Base and Competitors
Table 28. AbbVie Major Business
Table 29. AbbVie Brand Drugs Product and Services
Table 30. AbbVie Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 32. Gilead Sciences Major Business
Table 33. Gilead Sciences Brand Drugs Product and Services
Table 34. Gilead Sciences Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. GlaxoSmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table 36. GlaxoSmithKline (GSK) Major Business
Table 37. GlaxoSmithKline (GSK) Brand Drugs Product and Services
Table 38. GlaxoSmithKline (GSK) Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Amgen Basic Information, Manufacturing Base and Competitors
Table 40. Amgen Major Business
Table 41. Amgen Brand Drugs Product and Services
Table 42. Amgen Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Brand Drugs Product and Services
Table 46. AstraZeneca Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 48. Bristol-Myers Squibb Major Business
Table 49. Bristol-Myers Squibb Brand Drugs Product and Services
Table 50. Bristol-Myers Squibb Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 52. Eli Lilly Major Business
Table 53. Eli Lilly Brand Drugs Product and Services
Table 54. Eli Lilly Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Teva Basic Information, Manufacturing Base and Competitors
Table 56. Teva Major Business
Table 57. Teva Brand Drugs Product and Services
Table 58. Teva Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Bayer Basic Information, Manufacturing Base and Competitors
Table 60. Bayer Major Business
Table 61. Bayer Brand Drugs Product and Services
Table 62. Bayer Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 64. Novo Nordisk Major Business
Table 65. Novo Nordisk Brand Drugs Product and Services
Table 66. Novo Nordisk Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Allergan Basic Information, Manufacturing Base and Competitors
Table 68. Allergan Major Business
Table 69. Allergan Brand Drugs Product and Services
Table 70. Allergan Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Takeda Basic Information, Manufacturing Base and Competitors
Table 72. Takeda Major Business
Table 73. Takeda Brand Drugs Product and Services
Table 74. Takeda Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 76. Boehringer Ingelheim Major Business
Table 77. Boehringer Ingelheim Brand Drugs Product and Services
Table 78. Boehringer Ingelheim Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Takeda Basic Information, Manufacturing Base and Competitors
Table 80. Takeda Major Business
Table 81. Takeda Brand Drugs Product and Services
Table 82. Takeda Brand Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Global Brand Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 84. Global Brand Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 85. Market Position of Manufacturers in Brand Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 86. Global Brand Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and Brand Drugs Production Site of Key Manufacturer
Table 88. Brand Drugs New Entrant and Capacity Expansion Plans
Table 89. Brand Drugs Mergers & Acquisitions in the Past Five Years
Table 90. Global Brand Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Global Brand Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Global Brand Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Global Brand Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Global Brand Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Global Brand Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Global Brand Drugs Revenue by Type (2017-2022) & (USD Million)
Table 97. Global Brand Drugs Revenue by Type (2023-2028) & (USD Million)
Table 98. Global Brand Drugs Price by Type (2017-2022) & (USD/Unit)
Table 99. Global Brand Drugs Price by Type (2023-2028) & (USD/Unit)
Table 100. Global Brand Drugs Sales by Application (2017-2022) & (K Units)
Table 101. Global Brand Drugs Sales by Application (2023-2028) & (K Units)
Table 102. Global Brand Drugs Revenue by Application (2017-2022) & (USD Million)
Table 103. Global Brand Drugs Revenue by Application (2023-2028) & (USD Million)
Table 104. Global Brand Drugs Price by Application (2017-2022) & (USD/Unit)
Table 105. Global Brand Drugs Price by Application (2023-2028) & (USD/Unit)
Table 106. North America Brand Drugs Sales by Country (2017-2022) & (K Units)
Table 107. North America Brand Drugs Sales by Country (2023-2028) & (K Units)
Table 108. North America Brand Drugs Revenue by Country (2017-2022) & (USD Million)
Table 109. North America Brand Drugs Revenue by Country (2023-2028) & (USD Million)
Table 110. North America Brand Drugs Sales by Type (2017-2022) & (K Units)
Table 111. North America Brand Drugs Sales by Type (2023-2028) & (K Units)
Table 112. North America Brand Drugs Sales by Application (2017-2022) & (K Units)
Table 113. North America Brand Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Europe Brand Drugs Sales by Country (2017-2022) & (K Units)
Table 115. Europe Brand Drugs Sales by Country (2023-2028) & (K Units)
Table 116. Europe Brand Drugs Revenue by Country (2017-2022) & (USD Million)
Table 117. Europe Brand Drugs Revenue by Country (2023-2028) & (USD Million)
Table 118. Europe Brand Drugs Sales by Type (2017-2022) & (K Units)
Table 119. Europe Brand Drugs Sales by Type (2023-2028) & (K Units)
Table 120. Europe Brand Drugs Sales by Application (2017-2022) & (K Units)
Table 121. Europe Brand Drugs Sales by Application (2023-2028) & (K Units)
Table 122. Asia-Pacific Brand Drugs Sales by Region (2017-2022) & (K Units)
Table 123. Asia-Pacific Brand Drugs Sales by Region (2023-2028) & (K Units)
Table 124. Asia-Pacific Brand Drugs Revenue by Region (2017-2022) & (USD Million)
Table 125. Asia-Pacific Brand Drugs Revenue by Region (2023-2028) & (USD Million)
Table 126. Asia-Pacific Brand Drugs Sales by Type (2017-2022) & (K Units)
Table 127. Asia-Pacific Brand Drugs Sales by Type (2023-2028) & (K Units)
Table 128. Asia-Pacific Brand Drugs Sales by Application (2017-2022) & (K Units)
Table 129. Asia-Pacific Brand Drugs Sales by Application (2023-2028) & (K Units)
Table 130. South America Brand Drugs Sales by Country (2017-2022) & (K Units)
Table 131. South America Brand Drugs Sales by Country (2023-2028) & (K Units)
Table 132. South America Brand Drugs Revenue by Country (2017-2022) & (USD Million)
Table 133. South America Brand Drugs Revenue by Country (2023-2028) & (USD Million)
Table 134. South America Brand Drugs Sales by Type (2017-2022) & (K Units)
Table 135. South America Brand Drugs Sales by Type (2023-2028) & (K Units)
Table 136. South America Brand Drugs Sales by Application (2017-2022) & (K Units)
Table 137. South America Brand Drugs Sales by Application (2023-2028) & (K Units)
Table 138. Middle East & Africa Brand Drugs Sales by Region (2017-2022) & (K Units)
Table 139. Middle East & Africa Brand Drugs Sales by Region (2023-2028) & (K Units)
Table 140. Middle East & Africa Brand Drugs Revenue by Region (2017-2022) & (USD Million)
Table 141. Middle East & Africa Brand Drugs Revenue by Region (2023-2028) & (USD Million)
Table 142. Middle East & Africa Brand Drugs Sales by Type (2017-2022) & (K Units)
Table 143. Middle East & Africa Brand Drugs Sales by Type (2023-2028) & (K Units)
Table 144. Middle East & Africa Brand Drugs Sales by Application (2017-2022) & (K Units)
Table 145. Middle East & Africa Brand Drugs Sales by Application (2023-2028) & (K Units)
Table 146. Brand Drugs Raw Material
Table 147. Key Manufacturers of Brand Drugs Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Brand Drugs Typical Distributors
Table 151. Brand Drugs Typical Customers
List of Figures
Figure 1. Brand Drugs Picture
Figure 2. Global Brand Drugs Revenue Market Share by Type in 2021
Figure 3. Biopharmaceutical
Figure 4. Chemistry Medicine
Figure 5. Global Brand Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Brand Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Brand Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Brand Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Brand Drugs Price (2017-2028) & (USD/Unit)
Figure 13. Global Brand Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Brand Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Brand Drugs Market Drivers
Figure 16. Brand Drugs Market Restraints
Figure 17. Brand Drugs Market Trends
Figure 18. Global Brand Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Brand Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Brand Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Brand Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Brand Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Brand Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Brand Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Brand Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Brand Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Brand Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Brand Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Brand Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Brand Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Brand Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Brand Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Brand Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Brand Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Brand Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Brand Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Brand Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Brand Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Brand Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Brand Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Brand Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Brand Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Brand Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Brand Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Brand Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Brand Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Brand Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Brand Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Brand Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Brand Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Brand Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Brand Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Brand Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Brand Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Brand Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Brand Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Brand Drugs in 2021
Figure 77. Manufacturing Process Analysis of Brand Drugs
Figure 78. Brand Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
| 【ブランド医薬品について】 ブランド医薬品は、製薬会社が自社の商標名で販売する医薬品のことを指します。この種類の医薬品は、特定の成分、効能及び安全性を有する製品として、通常は特許によって保護されています。ブランド医薬品の特徴、種類、用途、関連技術について、以下に詳しく説明いたします。 ブランド医薬品の定義としては、特定の製薬会社が研究・開発を行い、販売する際に付けられた商標名を持つ薬剤です。ブランド名は、製薬会社のアイデンティティや製品の品質を訴求する役割を持っています。過去には、製薬会社による独自の研究開発を経て、医薬品の効果や副作用が確認されることで、ブランド医薬品として市場に登場することが多くありました。 ブランド医薬品の特徴には、専有性と品質の確保が挙げられます。特許によって保護されているため、他の企業が同じ成分で製品を作ることはできず、特定の企業のみがその製品を製造・販売する権利を持っています。このような環境は、研究開発に対する投資を行った企業に利益をもたらし、品質の高い医薬品を提供する動機付けとなります。さらに、ブランド医薬品は通常、厳格な試験と承認プロセスを経て市場に出るため、効果や安全性が確保されています。 ブランド医薬品の種類には、さまざまな分類方法があります。一般的には、治療対象に応じて分類されることが多いです。たとえば、痛みを緩和する鎮痛剤、感染症を治療する抗生物質、高血圧の治療に用いられる降圧剤、人の免疫系を調整する免疫抑制剤などが存在します。また、治療の対象となる病気や症状に基づく分類に加えて、その性質によっても分けられます。たとえば、化学合成による製剤、天然物由来の製剤、バイオ医薬品などがあります。 ブランド医薬品の用途は、多岐にわたります。基本的には、特定の病気や症状の治療、予防、そして診断に使用されます。例えば、がん治療に用いる抗がん剤や、慢性疾患の管理に使われる治療薬、心疾患や糖尿病治療に使われる特効薬などがあります。これらの薬剤は、医師の判断のもとに処方され、患者はその指示に従って服用します。 さらに、ブランド医薬品は製薬業界での先進的な技術の応用によっても進化しています。近年では、バイオテクノロジーの発展により、ヒトの細胞や生体成分を利用した医薬品が増えてきています。これには、モノクローナル抗体、ワクチン、遺伝子治療などが含まれます。これらの新しい技術は、より特異的かつ効果的な治療を可能にし、従来の化学合成医薬品では解決できなかった病気に対する新たな治療法の発展を支えています。 ブランド医薬品とジェネリック医薬品の違いも重要な要素です。ジェネリック医薬品は、ブランド医薬品の特許が切れた後に他の製薬会社が製造する同じ成分の薬剤であり、ブランド名は持たず、コストが低いことが特徴とされます。ジェネリック薬の登場は、医療費の削減に貢献するとともに、患者にとっての薬の入手可能性を高める効果がありますが、ブランド医薬品の持つ高い品質や効果の確保という側面では異なる議論も存在します。 さらに、ブランド医薬品の市場における競争は、ヘルスケア業界全体に影響を与えています。研究開発においては、高性能な医薬品を開発することに焦点を当てることで、新しい治療法を提供し、より多くの患者のニーズに応えていくことが求められています。また、消費者の意識が高まる中で、医薬品の安全性や副作用に関する情報を提供することも製薬会社にとって重要な責任となっています。 加えて、ブランド医薬品の販売促進戦略には様々な要素が含まれます。製薬会社は、医師向けの情報提供や医療機関との連携を通じて、ブランド医薬品の使用を促進してきました。さらに、患者向けの教育プログラムや広報活動を通じて、患者が抱える健康問題に対する理解を深める努力も行われています。このような戦略は、ブランド価値の向上や市場シェアの拡大を目指す上で必須の要素となっています。 ブランド医薬品には、社会的責任や倫理的考慮も絡み合います。特に、薬剤の価格設定やアクセスの問題は、近年の医療政策において重要なテーマとなっています。価格が高騰することで、一定の医薬品が患者にとって手の届かないものとなる可能性があり、その結果、医療格差が広がる危険性があります。これに対処するためには、製薬会社と政府、医療機関が協力し、患者が公平に医療を受けられる環境を整備することが重要です。 最後に、将来的には、デジタルヘルスや人工知能（AI）の技術が進化することで、ブランド医薬品の開発プロセスや患者への提供方法が大きく変わる可能性があります。例えば、AIを用いた創薬や、デジタルデータを活用した治療法の最適化によって、効果的な医薬品の開発が加速され、より個別化された医療が実現されるでしょう。 ブランド医薬品は、その特性や応用範囲の広さから、現代社会において欠かせない存在です。患者の健康や治療に多大な影響を与えるこれらの医薬品は、今後も進化し続け、より多くの人々に貢献することが期待されます。 |